共 112 条
[1]
Kodama I(1999)Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent Am J Cardiol 84 20R-28R
[2]
Kamiya K(1997)Cellular electropharmacology of amiodarone Cardiovasc Res 35 13-29
[3]
Toyama J(1992)Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias Drugs 43 69-110
[4]
Kodama I(1994)Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet 344 493-498
[5]
Kamiya K(1996)Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent Am J Cardiol. 78 41-53
[6]
Toyama J(1983)Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias J Am Coll Cardiol 2 1114-1128
[7]
Gill J(1982)Amiodarone pulmonary toxicity Ann Intern Med 97 839-845
[8]
Heel RC(1989)Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients Hepatology 9 679-685
[9]
Fitton A(2001)The effects of amiodarone on the thyroid Endocr Rev 22 240-254
[10]
Doval HC(1984)Frequent neurologic toxicity associated with amiodarone therapy Neurology 34 669-671